MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
15.94
-0.21
-1.30%
Closed 18:10 05/11 EDT
OPEN
16.18
PREV CLOSE
16.15
HIGH
16.46
LOW
15.70
VOLUME
3.26M
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
15.70
MARKET CAP
4.51B
P/E (TTM)
-4.9545
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Caris Life Sciences, Inc. (CAI)
TipRanks · 10h ago
Caris Life Sciences announces publication of study on measuring TMB using WES
TipRanks · 23h ago
Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels
PUBT · 1d ago
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
PR Newswire · 1d ago
Guggenheim Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)
TipRanks · 1d ago
Weekly Report: what happened at CAI last week (0504-0508)?
Weekly Report · 1d ago
Stronger Q1 Results And New AI Oncology Tests Could Be A Game Changer For Caris Life Sciences (CAI)
Simply Wall St · 1d ago
Caris Life Sciences (CAI) Turns Q4 Profit After US$517 Million Quarterly Loss Testing Bullish Thesis
Simply Wall St · 3d ago
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.